Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Non-cash Items (2016 - 2025)

Historic Non-cash Items for Collegium Pharmaceutical (COLL) over the last 10 years, with Q3 2025 value amounting to $66.2 million.

  • Collegium Pharmaceutical's Non-cash Items rose 2230.59% to $66.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $66.2 million, marking a year-over-year increase of 2230.59%. This contributed to the annual value of $7.0 million for FY2024, which is 50826.67% up from last year.
  • Per Collegium Pharmaceutical's latest filing, its Non-cash Items stood at $66.2 million for Q3 2025, which was up 2230.59% from $76.7 million recorded in Q2 2025.
  • Collegium Pharmaceutical's Non-cash Items' 5-year high stood at $82.4 million during Q1 2025, with a 5-year trough of $6.1 million in Q4 2021.
  • In the last 5 years, Collegium Pharmaceutical's Non-cash Items had a median value of $52.3 million in 2024 and averaged $47.3 million.
  • Its Non-cash Items has fluctuated over the past 5 years, first plummeted by 5334.72% in 2021, then surged by 6719.48% in 2023.
  • Quarter analysis of 5 years shows Collegium Pharmaceutical's Non-cash Items stood at $6.1 million in 2021, then soared by 31.02% to $8.0 million in 2022, then skyrocketed by 67.19% to $13.3 million in 2023, then tumbled by 47.02% to $7.0 million in 2024, then surged by 840.34% to $66.2 million in 2025.
  • Its Non-cash Items stands at $66.2 million for Q3 2025, versus $76.7 million for Q2 2025 and $82.4 million for Q1 2025.